Hong Guo

1.1k citations
36 papers · 801 indexed · h-index 14
Topics
MicroRNA in disease regulation (11 papers)Cancer-related molecular mechanisms research (7 papers)Circular RNAs in diseases (6 papers)

In The Last Decade

Hong Guo

32 papers receiving 794 citations

Peers

Hong Guo
Comparison fields: 5 of 77
  • Cancer Research 545
  • Molecular Biology 529
  • Immunology 106
  • Surgery 102
  • Oncology 66
Replace Katherine Rhodes with:
Katherine Rhodes United States
Virginie Dangles‐Marie France
Kati Pulkkinen Finland
Salvatore Simmini Netherlands
Agnès Mialhe France
Roberta Zuntini Italy
Toshina Ishiguro‐Oonuma Japan
Anne Langheinz Germany
Sven Kroening Germany
Avedis Kazanjian United States
Hong Guo relative to Katherine Rhodes United States Katherine Rhodes's profile →
Citations per field
00.5×3.7×
Katherine Rhodes · 1×
Citations per year

Countries citing papers authored by Hong Guo

Since Specialization
Citations

This map shows the geographic impact of Hong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Guo more than expected).

Fields of papers citing papers by Hong Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Guo. The network helps show where Hong Guo may publish in the future.

Co-authorship network of co-authors of Hong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Guo. A scholar is included among the top collaborators of Hong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Guo. Hong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 1
5 3
6 2
7 13
8 13
9 13
10 5
11 17
12 24
13 11
14 14
15 11
16
Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia.
5
17 41
18 95
19 238
20 6

About Hong Guo

Hong Guo is a scholar working on Cancer Research, Hematology and Molecular Biology, having authored 36 papers that have together received 801 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Cancer Research (545 citations), Molecular Biology (529 citations) and Immunology (106 citations). Hong Guo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yun Bai, Gang Xiong, Kang Yang, Xingying Guan, Xueqing Xu, Yun Shi, Fengjun Wang, Wei Li, Bin Tang and Wende Tong. Their work appears in journals such as Oncogene, Biochemical and Biophysical Research Communications and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026